Australia markets open in 3 hours 24 minutes

Catalyst Biosciences, Inc. (CBIO)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
0.4835+0.0035 (+0.73%)
At close: 04:00PM EDT
0.4750 -0.01 (-1.76%)
After hours: 04:12PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 15.40M
Enterprise value -58.57M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)2.78
Price/book (mrq)0.19
Enterprise value/revenue -10.59
Enterprise value/EBITDA 0.89

Trading information

Stock price history

Beta (5Y monthly) 1.35
52-week change 3-59.43%
S&P500 52-week change 3-16.03%
52-week high 31.2280
52-week low 30.0920
50-day moving average 30.4953
200-day moving average 30.2943

Share statistics

Avg vol (3-month) 33.61M
Avg vol (10-day) 32.35M
Shares outstanding 531.48M
Implied shares outstanding 6N/A
Float 823.99M
% held by insiders 115.06%
% held by institutions 125.95%
Shares short (30 Aug 2022) 41.97M
Short ratio (30 Aug 2022) 44.27
Short % of float (30 Aug 2022) 46.32%
Short % of shares outstanding (30 Aug 2022) 46.27%
Shares short (prior month 28 July 2022) 41.31M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 319 Sept 2022
Ex-dividend date 420 Sept 2022
Last split factor 23803:1000
Last split date 320 Sept 2022

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)29 June 2022


Profit margin -153.10%
Operating margin (ttm)-1,098.68%

Management effectiveness

Return on assets (ttm)-41.04%
Return on equity (ttm)-10.32%

Income statement

Revenue (ttm)5.53M
Revenue per share (ttm)0.18
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)-64.91M
EBITDA -60.41M
Net income avi to common (ttm)-8.47M
Diluted EPS (ttm)-2.5480
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)75.39M
Total cash per share (mrq)2.39
Total debt (mrq)1.42M
Total debt/equity (mrq)1.79
Current ratio (mrq)18.86
Book value per share (mrq)2.51

Cash flow statement

Operating cash flow (ttm)-63.62M
Levered free cash flow (ttm)-42.32M